Loading…
Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage
Aneurysmal subarachnoid hemorrhage (SAH) affects relatively young people and carries a poor prognosis with a case fatality rate of 35%. One of the major systemic complications associated with SAH is acute lung injury (ALI) which occurs in up to one-third of the patients and is associated with poor o...
Saved in:
Published in: | Critical care (London, England) England), 2010-01, Vol.14 (4), p.R157-R157, Article R157 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553 |
---|---|
cites | cdi_FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553 |
container_end_page | R157 |
container_issue | 4 |
container_start_page | R157 |
container_title | Critical care (London, England) |
container_volume | 14 |
creator | Cobelens, Pieter M Tiebosch, Ivo A C W Dijkhuizen, Rick M van der Meide, Peter H Zwartbol, René Heijnen, Cobi J Kesecioglu, Jozef van den Bergh, Walter M |
description | Aneurysmal subarachnoid hemorrhage (SAH) affects relatively young people and carries a poor prognosis with a case fatality rate of 35%. One of the major systemic complications associated with SAH is acute lung injury (ALI) which occurs in up to one-third of the patients and is associated with poor outcome. ALI in SAH may be predisposed by neurogenic pulmonary edema (NPE) and inflammatory mediators. The objective of this study was to assess the immunomodulatory effects of interferon-β (IFN-β) on inflammatory mediators in the lung after experimental SAH.
Male Wistar rats were subjected to the induction of SAH by means of the endovascular filament method. Sham-animals underwent sham-surgery. Rats received IFN-β for four consecutive days starting at two hours after SAH induction. After seven days, lungs were analyzed for the expression of inflammatory markers.
SAH induced the influx of neutrophils into the lung, and enhanced expression of the pulmonary adhesion molecules E-selectin, inter-cellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 compared to sham-animals. In addition, SAH increased the expression of the chemokines macrophage inflammatory protein (MIP)-1α, MIP-2, and cytokine-induced neutrophil chemoattractant (CINC)-1 in the lung. Finally, tumor necrosis factor-α (TNF-α) was significantly increased in lungs from SAH-animals compared to sham-animals. IFN-β effectively abolished the SAH-induced expression of all pro-inflammatory mediators in the lung.
IFN-β strongly reduces lung inflammation after experimental SAH and may therefore be an effective drug to prevent SAH-mediated lung injury. |
doi_str_mv | 10.1186/cc9232 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2945141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755176819</sourcerecordid><originalsourceid>FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553</originalsourceid><addsrcrecordid>eNp1kctOHDEQRa0oKDySfALqVVh18HvaG6RoxEtCYgNSsrJsT3nGkdse7G4gv5UP4ZtoNITHIitbrutzb1Uh9JXg74R08tA5RRn9gHYIl7KVWP38ON2Z5G0nmNhGu7X-xpjMOsk-oW2KZ4x0QuygX-dpgOKh5NQ-_G3MMEAazQC1iWNaNiH5aPreDCGnxucY812YnuF-DSX0kAYTmzpaU4xbpRwWzQr6XMrKLOEz2vImVvjyfO6h65Pjq_lZe3F5ej7_cdFaTsTQemDSTOmxlcJ5yrsFY8Qyrjy10i4oUVgRRTm2glnVCeyBMscYd5wSJwTbQ0cb7nq0PSzcFKqYqNdTPlP-6GyCfl9JYaWX-VZTxQXhZAKoDcCG_B_A-4rLvd7Me_p78Gxe8s0IddB9qA5iNAnyWPVMCDKTHVGT8ttG6UqutYB_MSBYP63wFbn_tp8X2b-dsUfPypuN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>755176819</pqid></control><display><type>article</type><title>Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage</title><source>PubMed Central</source><creator>Cobelens, Pieter M ; Tiebosch, Ivo A C W ; Dijkhuizen, Rick M ; van der Meide, Peter H ; Zwartbol, René ; Heijnen, Cobi J ; Kesecioglu, Jozef ; van den Bergh, Walter M</creator><creatorcontrib>Cobelens, Pieter M ; Tiebosch, Ivo A C W ; Dijkhuizen, Rick M ; van der Meide, Peter H ; Zwartbol, René ; Heijnen, Cobi J ; Kesecioglu, Jozef ; van den Bergh, Walter M</creatorcontrib><description>Aneurysmal subarachnoid hemorrhage (SAH) affects relatively young people and carries a poor prognosis with a case fatality rate of 35%. One of the major systemic complications associated with SAH is acute lung injury (ALI) which occurs in up to one-third of the patients and is associated with poor outcome. ALI in SAH may be predisposed by neurogenic pulmonary edema (NPE) and inflammatory mediators. The objective of this study was to assess the immunomodulatory effects of interferon-β (IFN-β) on inflammatory mediators in the lung after experimental SAH.
Male Wistar rats were subjected to the induction of SAH by means of the endovascular filament method. Sham-animals underwent sham-surgery. Rats received IFN-β for four consecutive days starting at two hours after SAH induction. After seven days, lungs were analyzed for the expression of inflammatory markers.
SAH induced the influx of neutrophils into the lung, and enhanced expression of the pulmonary adhesion molecules E-selectin, inter-cellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 compared to sham-animals. In addition, SAH increased the expression of the chemokines macrophage inflammatory protein (MIP)-1α, MIP-2, and cytokine-induced neutrophil chemoattractant (CINC)-1 in the lung. Finally, tumor necrosis factor-α (TNF-α) was significantly increased in lungs from SAH-animals compared to sham-animals. IFN-β effectively abolished the SAH-induced expression of all pro-inflammatory mediators in the lung.
IFN-β strongly reduces lung inflammation after experimental SAH and may therefore be an effective drug to prevent SAH-mediated lung injury.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>DOI: 10.1186/cc9232</identifier><identifier>PMID: 20731855</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acute Lung Injury - drug therapy ; Acute Lung Injury - etiology ; Animals ; Chemokine CCL3 - analysis ; Chemokine CXCL1 - analysis ; E-Selectin - analysis ; Inflammation - drug therapy ; Intercellular Adhesion Molecule-1 - analysis ; Interferon-beta - therapeutic use ; Lung - chemistry ; Lung - drug effects ; Lung - pathology ; Male ; Neutrophil Infiltration - drug effects ; Rats ; Rats, Wistar ; Reverse Transcriptase Polymerase Chain Reaction ; Subarachnoid Hemorrhage - complications ; Subarachnoid Hemorrhage - drug therapy ; Tumor Necrosis Factor-alpha - analysis ; Vascular Cell Adhesion Molecule-1 - analysis</subject><ispartof>Critical care (London, England), 2010-01, Vol.14 (4), p.R157-R157, Article R157</ispartof><rights>Copyright ©2010 Cobelens et al.; licensee BioMed Central Ltd. 2010 Cobelens et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553</citedby><cites>FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945141/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945141/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20731855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cobelens, Pieter M</creatorcontrib><creatorcontrib>Tiebosch, Ivo A C W</creatorcontrib><creatorcontrib>Dijkhuizen, Rick M</creatorcontrib><creatorcontrib>van der Meide, Peter H</creatorcontrib><creatorcontrib>Zwartbol, René</creatorcontrib><creatorcontrib>Heijnen, Cobi J</creatorcontrib><creatorcontrib>Kesecioglu, Jozef</creatorcontrib><creatorcontrib>van den Bergh, Walter M</creatorcontrib><title>Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>Aneurysmal subarachnoid hemorrhage (SAH) affects relatively young people and carries a poor prognosis with a case fatality rate of 35%. One of the major systemic complications associated with SAH is acute lung injury (ALI) which occurs in up to one-third of the patients and is associated with poor outcome. ALI in SAH may be predisposed by neurogenic pulmonary edema (NPE) and inflammatory mediators. The objective of this study was to assess the immunomodulatory effects of interferon-β (IFN-β) on inflammatory mediators in the lung after experimental SAH.
Male Wistar rats were subjected to the induction of SAH by means of the endovascular filament method. Sham-animals underwent sham-surgery. Rats received IFN-β for four consecutive days starting at two hours after SAH induction. After seven days, lungs were analyzed for the expression of inflammatory markers.
SAH induced the influx of neutrophils into the lung, and enhanced expression of the pulmonary adhesion molecules E-selectin, inter-cellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 compared to sham-animals. In addition, SAH increased the expression of the chemokines macrophage inflammatory protein (MIP)-1α, MIP-2, and cytokine-induced neutrophil chemoattractant (CINC)-1 in the lung. Finally, tumor necrosis factor-α (TNF-α) was significantly increased in lungs from SAH-animals compared to sham-animals. IFN-β effectively abolished the SAH-induced expression of all pro-inflammatory mediators in the lung.
IFN-β strongly reduces lung inflammation after experimental SAH and may therefore be an effective drug to prevent SAH-mediated lung injury.</description><subject>Acute Lung Injury - drug therapy</subject><subject>Acute Lung Injury - etiology</subject><subject>Animals</subject><subject>Chemokine CCL3 - analysis</subject><subject>Chemokine CXCL1 - analysis</subject><subject>E-Selectin - analysis</subject><subject>Inflammation - drug therapy</subject><subject>Intercellular Adhesion Molecule-1 - analysis</subject><subject>Interferon-beta - therapeutic use</subject><subject>Lung - chemistry</subject><subject>Lung - drug effects</subject><subject>Lung - pathology</subject><subject>Male</subject><subject>Neutrophil Infiltration - drug effects</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Subarachnoid Hemorrhage - complications</subject><subject>Subarachnoid Hemorrhage - drug therapy</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><subject>Vascular Cell Adhesion Molecule-1 - analysis</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp1kctOHDEQRa0oKDySfALqVVh18HvaG6RoxEtCYgNSsrJsT3nGkdse7G4gv5UP4ZtoNITHIitbrutzb1Uh9JXg74R08tA5RRn9gHYIl7KVWP38ON2Z5G0nmNhGu7X-xpjMOsk-oW2KZ4x0QuygX-dpgOKh5NQ-_G3MMEAazQC1iWNaNiH5aPreDCGnxucY812YnuF-DSX0kAYTmzpaU4xbpRwWzQr6XMrKLOEz2vImVvjyfO6h65Pjq_lZe3F5ej7_cdFaTsTQemDSTOmxlcJ5yrsFY8Qyrjy10i4oUVgRRTm2glnVCeyBMscYd5wSJwTbQ0cb7nq0PSzcFKqYqNdTPlP-6GyCfl9JYaWX-VZTxQXhZAKoDcCG_B_A-4rLvd7Me_p78Gxe8s0IddB9qA5iNAnyWPVMCDKTHVGT8ttG6UqutYB_MSBYP63wFbn_tp8X2b-dsUfPypuN</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Cobelens, Pieter M</creator><creator>Tiebosch, Ivo A C W</creator><creator>Dijkhuizen, Rick M</creator><creator>van der Meide, Peter H</creator><creator>Zwartbol, René</creator><creator>Heijnen, Cobi J</creator><creator>Kesecioglu, Jozef</creator><creator>van den Bergh, Walter M</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage</title><author>Cobelens, Pieter M ; Tiebosch, Ivo A C W ; Dijkhuizen, Rick M ; van der Meide, Peter H ; Zwartbol, René ; Heijnen, Cobi J ; Kesecioglu, Jozef ; van den Bergh, Walter M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acute Lung Injury - drug therapy</topic><topic>Acute Lung Injury - etiology</topic><topic>Animals</topic><topic>Chemokine CCL3 - analysis</topic><topic>Chemokine CXCL1 - analysis</topic><topic>E-Selectin - analysis</topic><topic>Inflammation - drug therapy</topic><topic>Intercellular Adhesion Molecule-1 - analysis</topic><topic>Interferon-beta - therapeutic use</topic><topic>Lung - chemistry</topic><topic>Lung - drug effects</topic><topic>Lung - pathology</topic><topic>Male</topic><topic>Neutrophil Infiltration - drug effects</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Subarachnoid Hemorrhage - complications</topic><topic>Subarachnoid Hemorrhage - drug therapy</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><topic>Vascular Cell Adhesion Molecule-1 - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cobelens, Pieter M</creatorcontrib><creatorcontrib>Tiebosch, Ivo A C W</creatorcontrib><creatorcontrib>Dijkhuizen, Rick M</creatorcontrib><creatorcontrib>van der Meide, Peter H</creatorcontrib><creatorcontrib>Zwartbol, René</creatorcontrib><creatorcontrib>Heijnen, Cobi J</creatorcontrib><creatorcontrib>Kesecioglu, Jozef</creatorcontrib><creatorcontrib>van den Bergh, Walter M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cobelens, Pieter M</au><au>Tiebosch, Ivo A C W</au><au>Dijkhuizen, Rick M</au><au>van der Meide, Peter H</au><au>Zwartbol, René</au><au>Heijnen, Cobi J</au><au>Kesecioglu, Jozef</au><au>van den Bergh, Walter M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>14</volume><issue>4</issue><spage>R157</spage><epage>R157</epage><pages>R157-R157</pages><artnum>R157</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><abstract>Aneurysmal subarachnoid hemorrhage (SAH) affects relatively young people and carries a poor prognosis with a case fatality rate of 35%. One of the major systemic complications associated with SAH is acute lung injury (ALI) which occurs in up to one-third of the patients and is associated with poor outcome. ALI in SAH may be predisposed by neurogenic pulmonary edema (NPE) and inflammatory mediators. The objective of this study was to assess the immunomodulatory effects of interferon-β (IFN-β) on inflammatory mediators in the lung after experimental SAH.
Male Wistar rats were subjected to the induction of SAH by means of the endovascular filament method. Sham-animals underwent sham-surgery. Rats received IFN-β for four consecutive days starting at two hours after SAH induction. After seven days, lungs were analyzed for the expression of inflammatory markers.
SAH induced the influx of neutrophils into the lung, and enhanced expression of the pulmonary adhesion molecules E-selectin, inter-cellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 compared to sham-animals. In addition, SAH increased the expression of the chemokines macrophage inflammatory protein (MIP)-1α, MIP-2, and cytokine-induced neutrophil chemoattractant (CINC)-1 in the lung. Finally, tumor necrosis factor-α (TNF-α) was significantly increased in lungs from SAH-animals compared to sham-animals. IFN-β effectively abolished the SAH-induced expression of all pro-inflammatory mediators in the lung.
IFN-β strongly reduces lung inflammation after experimental SAH and may therefore be an effective drug to prevent SAH-mediated lung injury.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>20731855</pmid><doi>10.1186/cc9232</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1364-8535 |
ispartof | Critical care (London, England), 2010-01, Vol.14 (4), p.R157-R157, Article R157 |
issn | 1364-8535 1466-609X 1364-8535 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2945141 |
source | PubMed Central |
subjects | Acute Lung Injury - drug therapy Acute Lung Injury - etiology Animals Chemokine CCL3 - analysis Chemokine CXCL1 - analysis E-Selectin - analysis Inflammation - drug therapy Intercellular Adhesion Molecule-1 - analysis Interferon-beta - therapeutic use Lung - chemistry Lung - drug effects Lung - pathology Male Neutrophil Infiltration - drug effects Rats Rats, Wistar Reverse Transcriptase Polymerase Chain Reaction Subarachnoid Hemorrhage - complications Subarachnoid Hemorrhage - drug therapy Tumor Necrosis Factor-alpha - analysis Vascular Cell Adhesion Molecule-1 - analysis |
title | Interferon-β attenuates lung inflammation following experimental subarachnoid hemorrhage |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A55%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interferon-%CE%B2%20attenuates%20lung%20inflammation%20following%20experimental%20subarachnoid%20hemorrhage&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Cobelens,%20Pieter%20M&rft.date=2010-01-01&rft.volume=14&rft.issue=4&rft.spage=R157&rft.epage=R157&rft.pages=R157-R157&rft.artnum=R157&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/cc9232&rft_dat=%3Cproquest_pubme%3E755176819%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b415t-fe36acc90b65cf248d331b349f2b6bd2190919240b53b9850fe23c334c421c553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=755176819&rft_id=info:pmid/20731855&rfr_iscdi=true |